Epinephrine use in COVID-19: friend or foe?

Eur J Hosp Pharm. 2021 Jan;28(1):e1. doi: 10.1136/ejhpharm-2020-002295. Epub 2020 May 29.

Authors

Pan Luo¹, Dong Liu², Juan Li²

Affiliations

¹ Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
² Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China lijuan@tjh.tjmu.edu.cn l_d2069@163.com.

No abstract available

Keywords: infection control; infectious diseases & infestations; intensive & critical care; pathology; pharmacology.

Publication types

Letter
Comment

MeSH terms

COVID-19*
Catecholamines
Cytokine Release Syndrome
Epinephrine
Humans
SARS-CoV-2

Substances

Catecholamines
Epinephrine